AbCellera Biologics Inc. (ABCL): Depreciation & Amortization
Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$24.39M
Year ended 2023-12-31
+71.5%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $24.39M | -12.4% | 2024-02-20, From 2023-01-01 |
| 2022-12-31 | $27.84M | +92.7% | 2024-02-20, From 2022-01-01 |
| 2021-12-31 | $14.45M | +198.8% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $4.84M | +201.5% | 2022-02-25, From 2020-01-01 |
| 2019-12-31 | $1.60M | n/a | 2022-02-25, From 2019-01-01 |